Michelle Chen

Chief Business Officer at Insilico Medicine

Michelle Chen is the Chief Business Officer of Insilico Medicine, a leader in the AI-powered drug discovery and development company.

She is responsible for company’s strategies, business and corporate development, revenue growth and US operations. As a biotech executive, Michelle brings in 20+ years of experience in biopharma and technology industries, and worked at multi-national companies such as Roche, Merck, BioMarin, Agilent, as well as small biotech companies with a strong track record of success in BD&L, M&A, R&D, marketing, and product commercialization.

Michelle has a Ph.D. in Biochemistry from the University of Washington, did her postdoctoral work at UCSF, and received the Bioinformatics training at Stanford.